UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

Study highlights link between sleep disturbances and behavioral issues in preschool children

Study reveals a significant association between sleep disturbances and emotional and behavioral difficulties (EBDs) in preschool children, emphasizing the import

December 17, 2023

AI tool predicts lethal heart rhythm with 80% accuracy

In a Leicester study that looked at whether artificial intelligence (AI) can be used to predict whether a person was at risk of a lethal

March 28, 2024

FDA Clears Eversense® 365: The World’s First One-Year CGM System

What You Should Know: – Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system. – This

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.